SHE:002900 Revenue

Harbin Medisan Pharmaceutical had revenue of 205.03M CNY in the quarter ending March 31, 2025, a decrease of -16.93%. This brings the company's revenue in the last twelve months to 1.09B, down -0.07% year-over-year. In the year 2024, Harbin Medisan Pharmaceutical had annual revenue of 1.13B, down -4.58%.

Revenue (ttm)

1.09B

Revenue Growth

-0.07%

P/S Ratio

3.83

Revenue / Employee

432.47K

Employees

2,522

Market Cap

4.18B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.13B	-54.31M	-4.58%
Dec 31, 2023	1.19B	158.37M	15.40%
Jan 1, 2023	1.03B	82.61M	8.73%
Jan 1, 2022	945.80M	-393.08M	-29.36%
Dec 31, 2020	1.34B	-763.18M	-36.31%
Dec 31, 2019	Pro	Pro	Pro
Jan 1, 2019	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Sichuan Biokin Pharmaceutical	5.82B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings